4.4 Article

Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6

期刊

PEPTIDES
卷 32, 期 6, 页码 1187-1192

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.peptides.2011.03.009

关键词

Atopic dermatitis; Prostate cancer; Epidermal barrier; Protease inhibitor

资金

  1. Deutsche Forschungsgemeinschaft DFG [Me2037/3-1, SCHR305/4-1]
  2. Centre of Excellence 'Inflammation at Interfaces'
  3. Jagiellonian University [DS/9/WBBiB]
  4. Foundation for Polish Science [DPS/424-329/10]
  5. European Union [POIG.02.01.00-12-064/08]
  6. VIB
  7. Ghent University
  8. FWO-Vlaanderen [3G.0218.06, G.0226.09, 1.5.169.08]

向作者/读者索取更多资源

Kallikrein-related peptidases (KLKs) are a group of serine proteases, expressed in several tissues. Their activity is regulated by inhibitors including members of the serine protease of Kazal-type (SPINK) family. Recently, we discovered that SPINK6 is expressed in human skin and inhibits KLK5, KLK7, KLK14 but not KLK8. In this study we tested whether SPINK6 inhibits other members of the KLK family and caspase-14. Using chromogenic substrates, SPINK6 exhibited inhibitory activity against KLK12 and KLK13 with K-i around 1 nM, KLK4 with K-i = 27.3 nM, KLK6 with K-i = 140 nM, caspase-14 with a K-i approximating 1 mu M and no activity against KLK1, KLK3 and KLK11. Taken together, SPINK6 is a potent inhibitor of distinct KLKs members. (C) 2011 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据